Back
SPDR S&P Bank ETF Vs. Akero Therapeutics Industry Stock Comparison
Buy
77
KBE
SPDR S&P Bank ETF
Last Price:
$58.44
Seasonality Move:
2.6%
Sell
42
AKRO
Akero Therapeutics
Last Price:
$52.10
Seasonality Move:
25.71%
Buy
77
SPDR S&P Bank ETF (KBE)
is a Buy
Is SPDR S&P Bank ETF a Buy, Sell or Hold?
-
The current SPDR S&P Bank ETF [KBE] share price is $58.44. The Score for KBE is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
KBE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $52.08. The Score for AKRO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KBE Stock Price Chart
What is SPDR S&P Bank ETF's stock price today?
-
The SPDR S&P Bank ETF share price today is $58.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KBE is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $52.08The current trend is moderately bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
KBE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 16.13 | Buy |
Relative Strength Index (14 RSI): | 61.56 | Buy |
Chaikin Money Flow: | -64598 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.06 - 58.42) | Buy |
Bollinger Bands (100): | (50.25 - 56.47) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 49.78 | Sell |
Chaikin Money Flow: | -771778 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.65 - 55.11) | Sell |
Bollinger Bands (100): | (40.15 - 52.25) | Buy |
KBE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.13 | Buy |
20-day SMA: | 57.02 | Buy |
50-day SMA: | 55.02 | Buy |
200-day SMA: | 55.24 | Buy |
8-day EMA: | 52.04 | Buy |
20-day EMA: | 34.51 | Buy |
50-day EMA: | 17.58 | Buy |
200-day EMA: | 5.01 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.4 | Sell |
20-day SMA: | 52.96 | Sell |
50-day SMA: | 50.04 | Buy |
200-day SMA: | 39.84 | Buy |
8-day EMA: | 52.64 | Sell |
20-day EMA: | 52.51 | Sell |
50-day EMA: | 50.35 | Buy |
200-day EMA: | 41.57 | Buy |
SPDR S&P Bank ETF Earnings Growth & KBE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.64 per share.
SPDR S&P Bank ETF Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |